Skip to main content
Erschienen in: European Radiology 6/2014

01.06.2014 | Magnetic Resonance

Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI)

verfasst von: Nicola Schieda, Niamh Coffey, Previn Gulavita, Omran Al-Dandan, Wael Shabana, Trevor A. Flood

Erschienen in: European Radiology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Prostatic ductal adenocarcinoma (DCa) is an aggressive variant. The purpose of this study was to determine if T2 signal intensity (SI) differs from conventional adenocarcinoma (CCa).

Materials and methods

A retrospective study of patients who underwent preoperative MRI and prostatectomy between 2009 and 2012 was performed. T2 SI ratios (SIR) for tumour (T) to obturator internus muscle (M) and normal peripheral zone (PZ) were compared. Two radiologists evaluated the central gland/PZ to detect tumours and compared diagnostic accuracy.

Results

T2 SIR for DCa were 3.60 (T/M), 0.66 (T/PZ); 2.68 (T/M), 0.47 (T/PZ) for Gleason 9; 2.50 (T/M), 0.47 (T/PZ) for Gleason 7/8 and 3.95 (T/M), 0.73 (T/PZ) for Gleason 6 tumours. There was a difference in T2 T/M and T/PZ SIR between DCa and Gleason 9 (p = 0.003, p = 0.004) and Gleason 7/8 (p = 0.006, p = 0.002), but no difference in SIR between DCa and Gleason 6 tumours. The sensitivity for tumour detection was 0–27 % for DCa, 64–82 % for Gleason 9, 44–88 % for Gleason 7–8 and 0–20 % for Gleason 6. There was a difference in the sensitivity of detecting Gleason 9 and 7/8 tumours when compared to DCa (p = 0.004, p = 0.001).

Conclusions

DCa resembles Gleason score 6 tumour at T2-weighted MRI, which underestimates tumour grade and renders the tumour occult.

Key Points

Prostatic ductal adenocarcinoma is aggressive, resembling endometrial carcinoma at histopathology.
Prostatic ductal adenocarcinoma resembles Gleason score 6 tumour at T2-weighted MRI.
MRI grading may underestimate ductal adenocarcinoma based on increased T2 signal.
Literatur
1.
Zurück zum Zitat Dube VE, Farrow GM, Greene LF (1973) Prostatic adenocarcinoma of ductal origin. Cancer 32:402–409PubMedCrossRef Dube VE, Farrow GM, Greene LF (1973) Prostatic adenocarcinoma of ductal origin. Cancer 32:402–409PubMedCrossRef
2.
Zurück zum Zitat Bostwick DG, Kindrachuk RW, Rouse RV (1985) Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 9:595–609PubMedCrossRef Bostwick DG, Kindrachuk RW, Rouse RV (1985) Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 9:595–609PubMedCrossRef
3.
Zurück zum Zitat Brinker DA, Potter SR, Epstein JI (1999) Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 23:1471–1479PubMedCrossRef Brinker DA, Potter SR, Epstein JI (1999) Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 23:1471–1479PubMedCrossRef
4.
Zurück zum Zitat Epstein JI, Woodruff JM (1986) Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer 57:111–119PubMedCrossRef Epstein JI, Woodruff JM (1986) Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer 57:111–119PubMedCrossRef
5.
Zurück zum Zitat Lemberger RJ, Bishop MC, Bates CP, Blundell W, Ansell ID (1984) Carcinoma of the prostate of ductal origin. Br J Urol 56:706–709PubMedCrossRef Lemberger RJ, Bishop MC, Bates CP, Blundell W, Ansell ID (1984) Carcinoma of the prostate of ductal origin. Br J Urol 56:706–709PubMedCrossRef
6.
Zurück zum Zitat Orihuela E, Green JM (2008) Ductal prostate cancer: contemporary management and outcomes. Urol Oncol 26:368–371PubMedCrossRef Orihuela E, Green JM (2008) Ductal prostate cancer: contemporary management and outcomes. Urol Oncol 26:368–371PubMedCrossRef
7.
Zurück zum Zitat Humphrey PA (2012) Histological variants of prostatic carcinoma and their significance. Histopathology 60:59–74PubMedCrossRef Humphrey PA (2012) Histological variants of prostatic carcinoma and their significance. Histopathology 60:59–74PubMedCrossRef
8.
Zurück zum Zitat Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL (2010) Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol 184:2303–2307PubMedCentralPubMedCrossRef Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL (2010) Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol 184:2303–2307PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167–S180PubMedCrossRef Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167–S180PubMedCrossRef
10.
11.
Zurück zum Zitat Soylu FN, Eggener S, Oto A (2012) Local staging of prostate cancer with MRI. Diagn Interv Radiol 18:365–373PubMed Soylu FN, Eggener S, Oto A (2012) Local staging of prostate cancer with MRI. Diagn Interv Radiol 18:365–373PubMed
12.
Zurück zum Zitat Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328PubMedCrossRef Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328PubMedCrossRef
13.
Zurück zum Zitat Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection—a multireader study. Radiology 250:145–151PubMedCrossRef Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection—a multireader study. Radiology 250:145–151PubMedCrossRef
14.
Zurück zum Zitat Mazaheri Y, Hricak H, Fine SW et al (2009) Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 252:449–457PubMedCentralPubMedCrossRef Mazaheri Y, Hricak H, Fine SW et al (2009) Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 252:449–457PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Vargas HA, Akin O, Franiel T et al (2011) Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259:775–784PubMedCentralPubMedCrossRef Vargas HA, Akin O, Franiel T et al (2011) Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259:775–784PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449–458PubMedCrossRef Futterer JJ, Heijmink SW, Scheenen TW et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449–458PubMedCrossRef
17.
Zurück zum Zitat Delongchamps NB, Rouanne M, Flam T et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411–1418PubMedCrossRef Delongchamps NB, Rouanne M, Flam T et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411–1418PubMedCrossRef
18.
Zurück zum Zitat Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30:327–334PubMedCrossRef Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30:327–334PubMedCrossRef
19.
Zurück zum Zitat Turkbey B, Pinto PA, Mani H et al (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology 255:89–99PubMedCentralPubMedCrossRef Turkbey B, Pinto PA, Mani H et al (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology 255:89–99PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K (2010) Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging 31:625–631PubMedCrossRef Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K (2010) Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging 31:625–631PubMedCrossRef
22.
Zurück zum Zitat Stamatakis L, Siddiqui MM, Nix JW et al (2013) Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 119:3359–3366PubMedCrossRef Stamatakis L, Siddiqui MM, Nix JW et al (2013) Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 119:3359–3366PubMedCrossRef
23.
Zurück zum Zitat Turkbey B, Mani H, Aras O et al (2013) Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268:144–152PubMedCrossRef Turkbey B, Mani H, Aras O et al (2013) Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268:144–152PubMedCrossRef
24.
Zurück zum Zitat Hoeks CM, Hambrock T, Yakar D et al (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266:207–217PubMedCrossRef Hoeks CM, Hambrock T, Yakar D et al (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266:207–217PubMedCrossRef
25.
Zurück zum Zitat Westphalen AC, Rosenkrantz AB (2014) Prostate Imaging Reporting and Data System (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI. AJR Am J Roentgenol 202:121–123PubMedCrossRef Westphalen AC, Rosenkrantz AB (2014) Prostate Imaging Reporting and Data System (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI. AJR Am J Roentgenol 202:121–123PubMedCrossRef
26.
Zurück zum Zitat Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H (2008) Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology 246:168–176PubMedCrossRef Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H (2008) Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology 246:168–176PubMedCrossRef
28.
Zurück zum Zitat Hegde JV, Mulkern RV, Panych LP et al (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37:1035–1054PubMedCentralPubMedCrossRef Hegde JV, Mulkern RV, Panych LP et al (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37:1035–1054PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Kvale R, Moller B, Wahlqvist R et al (2009) Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int 103:1647–1654PubMedCrossRef Kvale R, Moller B, Wahlqvist R et al (2009) Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int 103:1647–1654PubMedCrossRef
30.
Zurück zum Zitat Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR (1998) Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 159:1247–1250PubMedCrossRef Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR (1998) Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 159:1247–1250PubMedCrossRef
31.
Zurück zum Zitat Beddy P, O'Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E (2012) FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics 32:241–254PubMedCrossRef Beddy P, O'Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E (2012) FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics 32:241–254PubMedCrossRef
33.
Zurück zum Zitat Jackson W, Hamstra DA, Johnson S et al (2013) Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy. Cancer 119:3287–3294PubMedCrossRef Jackson W, Hamstra DA, Johnson S et al (2013) Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy. Cancer 119:3287–3294PubMedCrossRef
34.
Zurück zum Zitat Mosse CA, Magi-Galluzzi C, Tsuzuki T, Epstein JI (2004) The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 28:394–398PubMedCrossRef Mosse CA, Magi-Galluzzi C, Tsuzuki T, Epstein JI (2004) The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 28:394–398PubMedCrossRef
35.
Zurück zum Zitat Kulkarni MV, Patton JA, Price RR (1986) Technical considerations for the use of surface coils in MRI. AJR Am J Roentgenol 147:373–378PubMedCrossRef Kulkarni MV, Patton JA, Price RR (1986) Technical considerations for the use of surface coils in MRI. AJR Am J Roentgenol 147:373–378PubMedCrossRef
36.
Zurück zum Zitat Meeks JJ, Zhao LC, Cashy J, Kundu S (2012) Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program. BJU Int 109:831–834PubMedCrossRef Meeks JJ, Zhao LC, Cashy J, Kundu S (2012) Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program. BJU Int 109:831–834PubMedCrossRef
37.
Zurück zum Zitat Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228–1242PubMedCrossRef Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228–1242PubMedCrossRef
38.
Zurück zum Zitat Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66PubMedCrossRef Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66PubMedCrossRef
39.
Zurück zum Zitat Langer DL, van der Kwast TH, Evans AJ et al (2010) Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 255:485–494PubMedCrossRef Langer DL, van der Kwast TH, Evans AJ et al (2010) Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 255:485–494PubMedCrossRef
40.
Zurück zum Zitat Kim BS, Kim TH, Kwon TG, Yoo ES (2012) Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer. Yonsei Med J 53:550–556PubMedCentralPubMedCrossRef Kim BS, Kim TH, Kwon TG, Yoo ES (2012) Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer. Yonsei Med J 53:550–556PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Eberhardt SC, Carter S, Casalino DD et al (2013) ACR appropriateness criteria prostate cancer—pretreatment detection, staging, and surveillance. J Am Coll Radiol 10:83–92PubMedCrossRef Eberhardt SC, Carter S, Casalino DD et al (2013) ACR appropriateness criteria prostate cancer—pretreatment detection, staging, and surveillance. J Am Coll Radiol 10:83–92PubMedCrossRef
42.
Zurück zum Zitat Bratan F, Niaf E, Melodelima C et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019–2029PubMedCrossRef Bratan F, Niaf E, Melodelima C et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019–2029PubMedCrossRef
Metadaten
Titel
Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI)
verfasst von
Nicola Schieda
Niamh Coffey
Previn Gulavita
Omran Al-Dandan
Wael Shabana
Trevor A. Flood
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 6/2014
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3150-9

Weitere Artikel der Ausgabe 6/2014

European Radiology 6/2014 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.